Stay updated on AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial
Sign up to get notified when there's something new on the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page.

Latest updates to the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe ClinicalTrials.gov site footer now displays a newer software revision label.SummaryDifference0.1%

- Check24 days agoChange DetectedA notice says NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434, and directs visitors to updates and FAQs.SummaryDifference0.9%

- Check31 days agoChange DetectedThe website footer now identifies the site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check38 days agoChange DetectedThe site footer revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check58 days agoChange DetectedThe study record history now shows revision 3.7.0 as the latest entry, replacing the previous 3.6.6. This change records an updated version of the study record in the history.SummaryDifference0.1%

- Check80 days agoChange DetectedThe study record history now shows a new version (v3.6.6) replacing the previous v3.6.5, indicating an administrative update to the page.SummaryDifference0.1%

Stay in the know with updates to AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page.